Skip to content

Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial

Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03581006
Enrollment
100
Registered
2018-07-10
Start date
2018-11-12
Completion date
2021-03-04
Last updated
2021-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Injury, Particulate Matter Inhalation Injury

Keywords

World Trade Center, Firefighters, FDNY, 9/11, Metabolomics, FIREHOUSE

Brief summary

This is a randomized-controlled unblinded clinical trial to investigate dietary intervention on metabolic biomarker assessment in World Trade Center (WTC) Lung Injury (LI) in firefighters. The purpose of this study is to evaluate biomarkers of metabolic dysregulation that have previously been found to predict WTC-LI in a case cohort study selected from the entire exposed firefighter cohort, and attempt to alter these metabolites using dietary intervention and a technology-supported behavioral modification program. Investigators will measure Pre/Post global metabolic expression in WTC-exposed, symptomatic firefighter serum sampled after 6-month intervention, as well as clinical outcomes of WTC-LI in the study group vs controls.

Detailed description

Investigators propose to measure metabolites on this expanded cohort with serum sampled before and after 6-month intervention with calorie restricted Mediterranean diet to: 1) determine the effects of a technology assisted calorie restricted diet on metabolic risk and lung function; 2) determine differences between usual care and intervention group using genomics and metabolomics that may be targetable markers for further evaluation; 3) quantify the metabolome and evaluate pre/post changes in BMI, FEV1, FeNo, vascular stiffness, and overall quality of life; and 4) explore dietary modification as treatment of WTC-LI. The biomarker profile of the cohort control will be useful for discovering biomarker associations with other disease manifestations such as: bronchial wall thickening on CT, obstruction on FEV1 /FVC ratio, bronchodilator response, methacholine reactivity, and other definitions of loss of FEV 1 . This cohort control will be an asset to future studies.

Interventions

DIETARY_SUPPLEMENTLow-Calorie Mediterranean Diet

Participants in the intervention group will receive 6 months of education and behavioral counseling with self-monitoring to help them adopt a Mediterranean-style, calorie-restricted diet, and engage in physical activity

COMBINATION_PRODUCTTechnology based monitoring and behavioral participation

Intervention participants will use smart phones to connect to intervention applications, WebEx, MyNetDiary

OTHERUsual care group

Control group, who will receive no dietary or behavioral intervention during the trial

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Age 21-90. 2. Born male sex and currently identify as genetic male 3. FDNY rescue and recovery worker. 4. Documented WTC exposure. 5. Enrolled in the FDNY WTC Health Program 6. Subjects are willing and able to consent for themselves to study enrollment 7. Subjects are willing and able to participate in study procedures 8. Are able to perform their activities of daily living independently 9. Are either light duty or retired FDNY Firefighters 10. Have an FEV1 less than the LLN of predicted for age/sex/weight documented at any time after 9/11/2001. 11. Have a BMI\>27 kg/m2 and \<50kg/m2 12. Willing and able to modify their diet and activity level. 13. Subjects who have a spirometry available within the last 36 months, and at their post-9/11 visits at the FDNY 14. Demonstrate minimal proficiency using a smart phone 15. Have means to accommodate transportation to/from in-person visits

Exclusion criteria

1. Have pre-existing and documented conditions or concurrent diagnoses, including (and not necessarily limited to) active cancer, severe heart disease, significant cognitive impairment, eating disorders, significant psychiatric illness, end-stage COPD, severe pulmonary hypertension, or organ transplant. 2. Concomitant use of interfering medication(s) or devices currently or within the month prior to enrollment, including anti-retrovirals, human monoclonal antibodies, supplemental daytime oxygen, and insulin pumps. 3. Severe gastrointestinal issues or illnesses that would prevent adherence to the proposed diets. 4. Severe kidney disease requiring dialysis 5. Severe liver disease requiring frequent medical intervention 6. Participating in other diet modification studies. 7. High dose steroid (\>20mg prednisone or equivalent) or other hormonal treatments/chemotherapy use in the last month, including testosterone supplementation. 8. Life-expectancy \< 6 months 9. BMI ≥50 kg/m2 or ≤27 kg/m2 10. Recent significant intentional or unintentional weight loss, defined as over 5% reduction in total body weight over the last month. (Blackburn Criteria). 11. Significant or severe alcohol abuse disorder

Design outcomes

Primary

MeasureTime frameDescription
Body mass index (BMI)4 YearsBody mass (weight in kg) divided by square of the body height (measured in meters), expressed in units kg/m\^2

Secondary

MeasureTime frameDescription
St. George's Respiratory Questionnaire (SGRQ)4 YearsAirways-disease specific paper questionnaire assessing symptoms, effect on activity level, and impact on quality of life.
Electrocardiogram (EKG)4 yearsNon-invasive brief electrical recording of heart rate and rhythm using electrodes placed on the chest
Fraction of exhaled nitrous oxide (FENO)4 yearsSimple breathing test to measure airway inflammation as often seen in asthma or particulate matter lung injury, measured in ppb.
Pulse Wave Velocity (PWV)4 yearsNon-invasive measurement to ascertain vascular stiffness, by measuring the velocity at which the blood pressure pulse propogates through the circulatory system. This is done using a simple non-invasive blood pressure cuff assessment at the carotid and femoral arteries. It is measured as a velocity, in meters/per second.
Individual microbiome profile - stool sample4 yearsSimple home collection of a stool sample using a sterile collection kit, provided to the human subject. Stool will be used to generate a microbiome profile unique to that individual, reported as bacterial species found in the gut flora, that may predict lung injury. There is no risk to the human subject aside that of providing a stool sample. All individual information is de-identified for personal protection.
6-minute walk test (6MWT)4 yearsSimple exercise capacity assessment measuring distance walked over 6 minutes, measured in meters.
Individual metabolomic profile - blood sample4 yearsRoutine blood testing via sterile phlebotomy to assess metabolic biomarkers that may or may not predict lung injury. These metabolites are generated in all individuals based on their dietary and exercise habits, underlying comorbidities, and unique metabolism. Measured in routine blood samples, and quantified based on unique chemical composition of that molecule. There is no additional risk to the human subject aside that of venipuncture.
Individual genomic profile - saliva sample4 yearsSimple home collection of sputum/saliva sample using a buccal swab kit, provided to the human subject. Saliva will be used to generate a genetic profile unique to that individual, reported as chromosomes, genes, and proteins that may predict lung injury. There is no risk to the human subject aside that of providing a sputum sample. All individual information is de-identified for personal protection.
Pulmonary Function using FEV Measure4 YearsForced expiratory volume (FEV) using spirometer that measures the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled.
Routine vital signs - Heart Rate4 yearsBrief assessment of heart rate (pulse) measured in beats/per minute
Routine vital signs - Blood Pressure4 yearsSubjects who have spirometry available within the last 36 months, and at their post-9/11 visits at the FDNY.
Routine vital signs - Body temperature4 yearsBrief assessment of body temperature using a basic thermometer under the tongue, measured in degrees Fahrenheit
Neck circumference4 yearsAssessment of neck circumference using basic measuring tape, recorded in centimeters
Waist circumference4 yearsAssessment of waist circumference using basic measuring tape, recorded in centimeters
Bioelectrical impedance analysis (BIA)4 yearsAssessment of lean body mass and total body fat percentage using an InBody bioelectrical impedance analysis scale.
Food Frequency Questionnaire4 yearsPaper assessment of typical dietary intake over previous one month, multiple choice answers
Short-form-36 (SF-36) questionnaire4 yearsGeneralized paper questionnaire for self-assessment of mental health, general health perception, and overall quality of life

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026